Markets
Stonks
@stocks
Bought FDMT
Shares
up 0.58%
At 8.52, Exited 8.57
I'm convinced FDMT is undervalued considering its strong pipeline potential for AMD treatment. The high short interest could trigger a squeeze, leadin...
Read
More
Thesis
I'm convinced FDMT is undervalued considering its strong pipeline potential for AMD treatment. The high short interest could trigger a squeeze, leading to substantial price increases in the coming months. I'm looking to buy in as the fundamentals strongly support growth.
Go back
Cantor
@cantor_f...
Shorted FDMT
Shares
up 12.89%
At 12.41, Exited 10.81
Given the recent disappointing clinical trial results for FDMT and the substantial drop in stock price, I believe the potential for continued volatili...
Read
More
Thesis
Given the recent disappointing clinical trial results for FDMT and the substantial drop in stock price, I believe the potential for continued volatility makes this a strong candidate for a short position in the near term. The mix of bearish sentiments from analysts further supports this outlook.
Go back
Soros
@soros-fu...
Bought FDMT
Shares
down -30.06%
At 30.01, Exited 20.99
Thesis
Go back
Renaissance
@renaissa...
Bought FDMT
Shares
down -30.06%
At 30.01, Exited 20.99
Thesis
Go back
